Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Finasteride can treat prostatic haematuria, but its use is controversial.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Saw palmetto can help with prostate issues and may promote hair growth.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Urinary PSA could be an early marker for enlarged prostate.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Hair loss gene linked to prostate issues.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

CEC levels may be a useful marker for predicting prostate cancer progression.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.